[HTML][HTML] Therapeutic targeting of isocitrate dehydrogenase mutant AML
P Boddu, G Borthakur - Expert Opinion on Investigational Drugs, 2017 - Taylor & Francis
The last decade has witnessed rapid advances in our understanding of molecular
leukemogenesis providing valuable insights from which to explore new therapeutic …
leukemogenesis providing valuable insights from which to explore new therapeutic …
[引用][C] Therapeutic targeting of isocitrate dehydrogenase mutant AML
P Boddu, G Borthakur - Expert Opinion on …, 2017 - mdanderson.elsevierpure.com
Therapeutic targeting of isocitrate dehydrogenase mutant AML — MD Anderson Cancer Center
Skip to main navigation Skip to search Skip to main content MD Anderson Cancer Center Home …
Skip to main navigation Skip to search Skip to main content MD Anderson Cancer Center Home …
[引用][C] Therapeutic targeting of isocitrate dehydrogenase mutant AML.
P Boddu, G Borthakur - Expert Opinion on Investigational Drugs, 2017 - europepmc.org
Therapeutic targeting of isocitrate dehydrogenase mutant AML. - Abstract - Europe PMC Sign
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
[引用][C] Therapeutic targeting of isocitrate dehydrogenase mutant AML
P Boddu, G Borthakur - Expert Opinion on Investigational Drugs, 2017 - cir.nii.ac.jp
Therapeutic targeting of isocitrate dehydrogenase mutant AML | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[引用][C] Therapeutic targeting of isocitrate dehydrogenase mutant AML
P Boddu, G Borthakur - Expert opinion on investigational …, 2017 - pubmed.ncbi.nlm.nih.gov
Therapeutic targeting of isocitrate dehydrogenase mutant AML Therapeutic targeting of
isocitrate dehydrogenase mutant AML Expert Opin Investig Drugs. 2017 May;26(5):525-530 …
isocitrate dehydrogenase mutant AML Expert Opin Investig Drugs. 2017 May;26(5):525-530 …